Ott said:"If the [fracture] risk is high, then we should start with an anabolic medication for 1-2 years. If the risk is medium, then use a bisphosphonate for up to 5 years, and then stop and monitor the patient for signs that the medicine is wearing off," based on blood and urine tests. Osteopenia is defined by an arbitrary bone density measurement, Ott explained."About half of women over 65 will have osteopenia, and by age 85 there are hardly any"normal" women left.
"An immediate [guideline] update is necessary to address the severity of bone loss and the high risk for vertebral fractures after discontinuation of denosumab," Ott urged. It is also unfortunate that the review and recommendations do not address estrogen, one of the most effective medications to prevent osteoporotic fractures, according to Ott.Clinicians treating adults with osteoporosis should encourage adherence to recommended treatments and healthy lifestyle habits, including exercise, and counseling to evaluate and prevent falls.intake, as part of fracture prevention.
gnosis? Nag Hammadi guideline for osteoporosis?